Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Response to Mycobacterium tuberculosis: A Narrative Review
Maurizio de Martino, Lorenzo Lodi, Luisa Galli, et al.
Frontiers in Pediatrics (2019) Vol. 7
Open Access | Times Cited: 281

Showing 1-25 of 281 citing articles:

Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge
Brian Allwood, Anthony Byrne, Jamilah Meghji, et al.
Respiration (2021) Vol. 100, Iss. 8, pp. 751-763
Open Access | Times Cited: 170
Cavitary tuberculosis: the gateway of disease transmission
Michael E. Urbanowski, Alvaro A. Ordoñez, Camilo A. Ruiz-Bedoya, et al.
The Lancet Infectious Diseases (2020) Vol. 20, Iss. 6, pp. e117-e128
Open Access | Times Cited: 157
T Cell Metabolism in Infection
Jonas Aakre Wik, Bjørn Steen Skålhegg
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 58
Clinical manifestations and immune response to tuberculosis
Mary Lilián Carabalí-Isajar, Oscar Hernán Rodríguez-Bejarano, Tatiana Amado, et al.
World Journal of Microbiology and Biotechnology (2023) Vol. 39, Iss. 8
Open Access | Times Cited: 44
Harnessing miRNAs: A Novel Approach to Diagnosis and Treatment of Tuberculosis
Ahmed S. Doghish, Ahmed I. Abulsoud, Yara A. Nassar, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 1
Closed Access | Times Cited: 2
Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery
Renuga Devi Kanabalan, Le Jie Lee, Tze Yan Lee, et al.
Microbiological Research (2021) Vol. 246, pp. 126674-126674
Closed Access | Times Cited: 102
B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis
Willemijn Rijnink, Tom H. M. Ottenhoff, Simone A. Joosten
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 79
Lymph nodes—The neglected battlefield in tuberculosis
Sharie Keanne C. Ganchua, Alexander G. White, Edwin Klein, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 8, pp. e1008632-e1008632
Open Access | Times Cited: 77
Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
Stefanie Krug, Sadiya Parveen, William R. Bishai
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection
Annuurun Nisa, Franciele Kipper, Dipak Panigrahy, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 5, pp. C1444-C1474
Open Access | Times Cited: 53
Mycobacterium tuberculosis infection drives a type I IFN signature in lung lymphocytes
Sadia Akter, Kuldeep S Chauhan, Micah Dunlap, et al.
Cell Reports (2022) Vol. 39, Iss. 12, pp. 110983-110983
Open Access | Times Cited: 44
Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis
Manish Gupta, Geetha Srikrishna, Sabra L. Klein, et al.
Trends in Immunology (2022) Vol. 43, Iss. 8, pp. 640-656
Open Access | Times Cited: 39
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Xiaoli Lou, De‐Yong Gao, Liyuan Yang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
Iman Satti, Julia L. Marshall, Stephanie A. Harris, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 909-921
Open Access | Times Cited: 14
HIV–TB Coinfection: Current Therapeutic Approaches and Drug Interactions
Inesa Navasardyan, Rita Miwalian, Aelita Petrosyan, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 321-321
Open Access | Times Cited: 11
Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis
Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132332-132332
Closed Access | Times Cited: 10
Targeting natural killer cells to enhance vaccine responses
Andrew Cox, Hilal Cevik, H. Alex Feldman, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 9, pp. 789-801
Open Access | Times Cited: 43
Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
Filia Stephanie, Mutiara Saragih, Usman Sumo Friend Tambunan
Pharmaceutics (2021) Vol. 13, Iss. 5, pp. 592-592
Open Access | Times Cited: 42
Diagnosis and biomarkers for ocular tuberculosis: From the present into the future
Zhang Ludi, Ashita Ashish Sule, Ramar Perumal Samy, et al.
Theranostics (2023) Vol. 13, Iss. 7, pp. 2088-2113
Open Access | Times Cited: 20
Effectiveness of Adjunctive High-Dose Infliximab Therapy to Improve Disability-Free Survival Among Patients With Severe Central Nervous System Tuberculosis: A Matched Retrospective Cohort Study
Abi Manesh, Priyanka Gautam, Selwyn Selva Kumar D, et al.
Clinical Infectious Diseases (2023) Vol. 77, Iss. 10, pp. 1460-1467
Closed Access | Times Cited: 20
The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois
Aniefiok John Udoakang, Alexandra Lindsey Djomkam Zune, Kesego Tapela, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Metal-Organic Framework-Based Nanomedicines for the Treatment of Intracellular Bacterial Infections
Xiaoli Qi, Ningfei Shen, Aya Al Othman, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1521-1521
Open Access | Times Cited: 19
Immunoinformatic-Based Multi-Epitope Vaccine Design for Co-Infection of Mycobacterium tuberculosis and SARS-CoV-2
Cong Peng, Fengjie Tang, Jie Wang, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 1, pp. 116-116
Open Access | Times Cited: 18
Role of B Cells in Mycobacterium Tuberculosis Infection
Paul A. Stewart, Shivani Patel, Andrew Comer, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 955-955
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top